BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Engstrand J, Strömberg C, Nilsson H, Freedman J, Jonas E. Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition. World J Surg Oncol 2019;17:228. [PMID: 31878952 DOI: 10.1186/s12957-019-1771-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Lino-Silva LS, Xinaxtle DL, Salcedo-Hernández RA. Tumor deposits in colorectal cancer: the need for a new "pN" category. Ann Transl Med 2020;8:733. [PMID: 32647658 DOI: 10.21037/atm.2020.03.175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Dmello RS, To SQ, Chand AL. Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer. Int J Mol Sci 2021;22:2067. [PMID: 33669775 DOI: 10.3390/ijms22042067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nassabein R, Mansour L, Richard C, Vandenbroucke-Menu F, Aubin F, Ayoub JP, Dagenais M, Lapointe R, Letourneau R, Plasse M, Roy A, Turcotte S, Tehfe M. Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience. Curr Oncol 2021;28:1899-908. [PMID: 34069871 DOI: 10.3390/curroncol28030176] [Reference Citation Analysis]
4 Wang HW, Yan XL, Wang LJ, Zhang MH, Yang CH, Wei-Liu, Jin KM, Bao Q, Li J, Wang K, Xing BC. Characterization of genomic alterations in Chinese colorectal cancer patients with liver metastases. J Transl Med 2021;19:313. [PMID: 34281583 DOI: 10.1186/s12967-021-02986-0] [Reference Citation Analysis]
5 Fiorentini G, Sarti D, Nardella M, Inchingolo R, Nestola M, Rebonato A, Fiorentini C, Aliberti C, Nani R, Guadagni S. Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases. Hepat Oncol 2022;9:HEP40. [PMID: 34765108 DOI: 10.2217/hep-2020-0031] [Reference Citation Analysis]
6 Inoue H, Kawaguchi T, Ikoma H, Morimura R, Yamamoto Y, Ochiai T, Shimizu H, Arita T, Konishi H, Shiozaki A, Kuriu Y, Kubota T, Fujiwara H, Okamoto K, Takahashi H, Takabe K, Tsung A, Otsuji E. Oligometastasis scoring system for predicting survival of patients with colorectal liver metastasis after hepatectomy. J Surg Oncol 2021;124:791-800. [PMID: 34196000 DOI: 10.1002/jso.26575] [Reference Citation Analysis]
7 Samoon Z, Naher SK, Sjoquist KM, Zalcberg J. Chemotherapy in resectable or potentially resectable colon cancer with liver metastases. Expert Opin Pharmacother 2022;:1-10. [PMID: 35196945 DOI: 10.1080/14656566.2022.2043276] [Reference Citation Analysis]
8 Berzenji D, Sewnaik A, Keereweer S, Monserez DA, Verduijn GM, van Meerten E, Mast H, Mureau MAM, van der Lugt A, Koljenovic S, Dronkers EAC, Baatenburg de Jong RJ, Hardillo JA. Dissemination patterns and chronology of distant metastasis affect survival of patients with head and neck squamous cell carcinoma. Oral Oncol 2021;119:105356. [PMID: 34034098 DOI: 10.1016/j.oraloncology.2021.105356] [Reference Citation Analysis]
9 Hao M, Li H, Wang K, Liu Y, Liang X, Ding L. Predicting metachronous liver metastasis in patients with colorectal cancer: development and assessment of a new nomogram. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02558-6] [Reference Citation Analysis]
10 Kasprzak A, Adamek A. The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management. Int J Mol Sci 2020;21:E3494. [PMID: 32429087 DOI: 10.3390/ijms21103494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Mulliri A, Gardy J, Cariou M, Launoy G, Robaszkiewicz M, Alves A, Bouvier V, Dejardin O. Care Management and Survival of Patients Diagnosed with Synchronous Metastatic Colorectal Cancer: A High-Resolution Population-Based Study in Two French Areas. Cancers 2022;14:1777. [DOI: 10.3390/cancers14071777] [Reference Citation Analysis]
12 Chen M, Zhong K, Tan J, Meng M, Liu CM, Chen B, Huang C, Wong HLX, Bian Z, Su T, Kwan HY. Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer. Clin Transl Med 2021;11:e564. [PMID: 34841696 DOI: 10.1002/ctm2.564] [Reference Citation Analysis]
13 Liu Y, Wang Y, Zhang H, Zheng M, Wang C, Hu Z, Wang Y, Xiong H, Hu H, Tang Q, Wang G. Nomogram for predicting occurrence of synchronous liver metastasis in colorectal cancer: a single-center retrospective study based on pathological factors. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02516-2] [Reference Citation Analysis]